Patent directory · USPTO A61K / A61P
Patents matching “Fulcrum Therapeutics, Inc.”
8 pharma patents match "Fulcrum Therapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 8 pharmaceutical patents matching "Fulcrum Therapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12109198
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 11819554
Compositions and methods for modulating FMR1 expression
granted -
US 11590111
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 11479770
Use of p38 inhibitors to reduce expression of DUX4
granted -
US 11291659
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10973805
Macrocyclic azolopyridine derivatives as EED and PRC2 modulators
granted -
US 10537560
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted -
US 10342786
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
granted